Published on
February 19, 2024
- 10:06 GMT
GlycanAge Secures $4.2 Million in Seed Funding to Revolutionize Personalized Preventative Care
LONDON, ENGLAND, UNITED KINGDOM, February 19, 2024 /EINPresswire.com/ -- GlycanAge, a biotech startup pioneering the field of glycan biomarkers, announced the successful completion of its $4.2 million seed funding round, led by venture capital fund …
Distribution channels:
Healthcare & Pharmaceuticals Industry
...
